KBC Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.7M | Buy |
38,473
+258
| +0.7% | +$198K | 0.07% | 219 |
|
|
2025
Q4 | $29.5M | Buy |
38,215
+4,953
| +15% | +$3.36M | 0.07% | 218 |
|
|
2025
Q3 | $18.7M | Sell |
33,262
-3,310
| -9% | -$1.87M | 0.04% | 276 |
|
|
2025
Q2 | $19.2M | Sell |
36,572
-112,868
| -76% | -$63M | 0.05% | 275 |
|
|
2025
Q1 | $94.8M | Buy |
149,440
+12,793
| +9% | +$8.8M | 0.29% | 69 |
|
|
2024
Q4 | $97.3M | Buy |
136,647
+102,198
| +297% | +$85.8M | 0.27% | 77 |
|
|
2024
Q3 | $36.2M | Buy |
34,449
+7
| +0% | +$7.79K | 0.11% | 184 |
|
|
2024
Q2 | $36.2M | Buy |
34,442
+188
| +0.5% | +$182K | 0.11% | 168 |
|
|
2024
Q1 | $33M | Sell |
34,254
-31,273
| -48% | -$29.7M | 0.1% | 188 |
|
|
2023
Q4 | $57.6M | Sell |
65,527
-1,058
| -2% | -$871K | 0.2% | 106 |
|
|
2023
Q3 | $54.8M | Sell |
66,585
-4,730
| -7% | -$3.72M | 0.22% | 98 |
|
|
2023
Q2 | $51.2M | Sell |
71,315
-4,531
| -6% | -$3.49M | 0.21% | 100 |
|
|
2023
Q1 | $62.3M | Sell |
75,846
-33,233
| -30% | -$25.1M | 0.26% | 82 |
|
|
2022
Q4 | $78.7M | Buy |
109,079
+46,999
| +76% | +$34.7M | 0.38% | 59 |
|
|
2022
Q3 | $42.8M | Sell |
62,080
-21,455
| -26% | -$13.5M | 0.22% | 104 |
|
|
2022
Q2 | $49.4M | Sell |
83,535
-3,217
| -4% | -$2.09M | 0.25% | 97 |
|
|
2022
Q1 | $60.6M | Sell |
86,752
-145,494
| -63% | -$92M | 0.24% | 109 |
|
|
2021
Q4 | $147M | Buy |
232,246
+87,909
| +61% | +$54M | 0.48% | 49 |
|
|
2021
Q3 | $87.3M | Sell |
144,337
-119,345
| -45% | -$74.1M | 0.32% | 72 |
|
|
2021
Q2 | $147M | Sell |
263,682
-31,746
| -11% | -$16.1M | 0.27% | 88 |
|
|
2021
Q1 | $140M | Buy |
295,428
+6,882
| +2% | +$3.35M | 0.28% | 80 |
|
|
2020
Q4 | $767M | Buy |
288,546
+30,924
| +12% | +$16.7M | 0.33% | 76 |
|
|
2020
Q3 | $144M | Buy |
257,622
+121,212
| +89% | +$73.5M | 0.43% | 53 |
|
|
2020
Q2 | $85.1M | Buy |
136,410
+104,047
| +321% | +$59.1M | 0.28% | 79 |
|
|
2020
Q1 | $15.8M | Sell |
32,363
-11,501
| -26% | -$4.74M | 0.13% | 174 |
|
|
2019
Q4 | $16.5M | Sell |
43,864
-1,288
| -3% | -$433K | 0.1% | 230 |
|
|
2019
Q3 | $12.5M | Sell |
45,152
-3,807
| -8% | -$1.13M | 0.09% | 268 |
|
|
2019
Q2 | $15.3M | Buy |
48,959
+9,912
| +25% | +$3.3M | 0.12% | 210 |
|
|
2019
Q1 | $16M | Buy |
39,047
+24,505
| +169% | +$10.1M | 0.13% | 195 |
|
|
2018
Q4 | $5.43M | Buy |
14,542
+2,023
| +16% | +$740K | 0.06% | 327 |
|
|
2018
Q3 | $5.06M | Buy |
12,519
+5,620
| +81% | +$2.14M | 0.04% | 431 |
|
|
2018
Q2 | $2.38M | Buy |
6,899
+315
| +5% | +$98.5K | 0.02% | 571 |
|
|
2018
Q1 | $2.27M | Sell |
6,584
-832
| -11% | -$289K | 0.02% | 545 |
|
|
2017
Q4 | $2.79M | Sell |
7,416
-1,731
| -19% | -$701K | 0.02% | 509 |
|
|
2017
Q3 | $4.09M | Buy |
9,147
+981
| +12% | +$467K | 0.04% | 436 |
|
|
2017
Q2 | $4.01M | Sell |
8,166
-153
| -2% | -$67K | 0.04% | 428 |
|
|
2017
Q1 | $3.22M | Buy |
8,319
+962
| +13% | +$357K | 0.03% | 523 |
|
|
2016
Q4 | $2.7M | Sell |
7,357
-4,225
| -36% | -$1.61M | 0.03% | 554 |
|
|
2016
Q3 | $4.66M | Sell |
11,582
-3,401
| -23% | -$1.36M | 0.06% | 357 |
|
|
2016
Q2 | $5.23M | Buy |
14,983
+649
| +5% | +$250K | 0.07% | 301 |
|
|
2016
Q1 | $5.17M | Sell |
14,334
-270
| -2% | -$111K | 0.09% | 278 |
|
|
2015
Q4 | $7.93M | Buy |
14,604
+1,767
| +14% | +$957K | 0.15% | 176 |
|
|
2015
Q3 | $5.97M | Sell |
12,837
-6,540
| -34% | -$3.51M | 0.12% | 216 |
|
|
2015
Q2 | $9.88M | Buy |
19,377
+9,769
| +102% | +$4.77M | 0.13% | 204 |
|
|
2015
Q1 | $4.34M | Sell |
9,608
-863
| -8% | -$366K | 0.06% | 350 |
|
|
2014
Q4 | $4.29M | Sell |
10,471
-290
| -3% | -$114K | 0.05% | 384 |
|
|
2014
Q3 | $3.88M | Sell |
10,761
-26,390
| -71% | -$8.84M | 0.14% | 210 |
|
|
2014
Q2 | $10.5M | Buy |
37,151
+2,130
| +6% | +$631K | 0.12% | 213 |
|
|
2014
Q1 | $10.5M | Buy |
35,021
+21,229
| +154% | +$6.54M | 0.17% | 161 |
|
|
2013
Q4 | $3.8M | Sell |
13,792
-9,680
| -41% | -$2.78M | 0.06% | 362 |
|
|
2013
Q3 | $7.34M | Buy |
23,472
+2,614
| +13% | +$688K | 0.12% | 231 |
|
|
2013
Q2 | $4.69M | Buy |
+20,858
| New | +$4.86M | 0.09% | 290 |
|
Other funds holding REGN
VCM
N
KBC Group's REGN Position: Q1 2026 in Review
KBC Group increased its Regeneron Pharmaceuticals (REGN) stake by 0.68% in Q1 2026, buying an estimated $198K and bringing the position to 38,473 shares worth $29.7M. The position accounts for 0.07% of the portfolio, ranked #219.
KBC Group first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $767M in Q4 2020. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- KBC Group held 38,473 shares of Regeneron Pharmaceuticals worth $29.7M as of Q1 2026.
- KBC Group bought 258 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $198K.
- Regeneron Pharmaceuticals made up 0.07% of KBC Group's portfolio in Q1 2026, its #219 holding.
- KBC Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- KBC Group's Regeneron Pharmaceuticals position peaked at $767M in Q4 2020.
- 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.